Skip to content

Characterization of Retinal Microvascular and FAZ Changes in Ischemic Stroke and Its Different Types

Characterization of Retinal Microvascular and FAZ Changes in Ischemic Stroke and Its Different Types

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05243849
Enrollment
100
Registered
2022-02-17
Start date
2022-01-01
Completion date
2022-06-30
Last updated
2022-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Keywords

Ischemic Stroke, Optical Coherence Tomography Angiography, Retina

Brief summary

The study aimed to access the microvascular changes in the superficial capillary plexus (SCP) and deep capillary plexus (DCP) in patients with ischemic stroke and its different types using optical coherence tomography angiography.

Detailed description

Investigators used OCTA to quantitatively access the retinal microvasculature of SCP and DCP, aiming to detect the geometry changes of retinal microvasculature and FAZ in ischemic stroke patients and its different types.

Interventions

DEVICEOptical Coherence Tomography Angiography

Optical coherence tomography angiography (OCTA) is a novel non-invasive, non-dye and high-resolution imaging technique, allowing real-time quantitative evaluation of retinal vasculature and the structure of foveal avascular zone (FAZ).

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

Patients who were diagnosed with ischemic stroke by MRI were scheduled for an OCTA examination. The diagnosis of ischemic stroke was obtained from previous diagnostic reports or electronic medical records, according to the diagnostic criteria from the Trial of Org 10172 in Acute Stroke Treatment (TOAST).

Exclusion criteria

1\) Retinal diseases or diseases affecting vessel structure in fundus photography, including age-related maculopathy; diabetic retinopathy, central serous chorioretinopathy, retinal pigment epithelial detachment and glaucoma); poor cooperation in ophthalmic examinations; high refractive error (\>+6.00 D or \<-6.00 D Spherical Equivalent); low-quality OCTA images (signal strength index \< 6/10). Inclusion criteria for healthy controls were no history of ischemic stroke or other neurological and ocular diseases.

Design outcomes

Primary

MeasureTime frameDescription
Vascular Area Density(VAD)immediately after meeting the inclusion and exclusion criteriaThe total length in millimeters of perfused retinal microvasculature per unit area in square millimeters in the annular region of analyzed area
Vascular Fractal Dimension(VFD)immediately after meeting the inclusion and exclusion criteriaA well-known parameter which indicates the degree of geometric complexity of vasculature
Vascular Orientation Distribution(VOD)immediately after meeting the inclusion and exclusion criteriaThe direction of each vascular pixel to indicate the trend of the blood flow
FAZ Area(FA)immediately after meeting the inclusion and exclusion criteriaThe total numbers of pixels in the FAZ region
FAZ Axis Ratio(FAR)immediately after meeting the inclusion and exclusion criteriaThe ratio between the major and minor axes of the fitted ellipse from the FAZ boundary. The axis ratio of a perfect circular FAZ is equal to 1
FAZ Circularity(FC)After meeting the inclusion and exclusion criteriaThe ratio of the perimeter of the FAZ to the parameter of a circle with equal area, reflecting the degree of roundness of the FAZ
FAZ Roundness(FR)immediately after meeting the inclusion and exclusion criteriaSimilar to FC, but is less sensitive to irregular borders along the parameter of FAZ

Countries

China

Contacts

Primary ContactHong Qi, PhD
doctorqihong@163.com13901066889
Backup ContactHongyu Duan, MD
hyduan167@163.com18813120970

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026